Subscribe to our Newsletters !!

    Chronic

    Hereditary components of human gut microbiota are key to wellbeing

    Neanderthals’ gut microbiota already contained some beneficial micro-organisms that are also found within our own intestine. An international research group headed by the University of Bologna achieved this result by extracting and analyzing ancient DNA from 50,000-year-old fecal sediments sampled at the archaeological site of El Salt, near Alicante (Spain). Published in Communication Biology, their

    Study distinguishes top factor for life span in clinical research coordinator positions

    Danielle Buchanan, BS, clinical translational research coordinator III in the Department of Neurology, and Daniel Claassen, MD, MS, chief of the Division of Psychological Disorders and associate professor of Neurology, found the top element for retention is a close working relationship between clinical research coordinators (CRCs) and the study’s principal investigator that emphasizes respect and

    Novel device can add or eliminate sugar from proteins

    Sugar has been called “evil,” “toxic,” and “poison.” But the body needs sugars, also. Sugar molecules help cells recognize and fight germs and viruses, shuttle proteins from cell to cell, and make sure those proteins function. Too much or too small can give rise to a range of maladies, including neurodegenerative diseases like Alzheimer’s, diabetes,

    VR offers desire to nerve injury patients encountering chronic pain

    We all feel physical pain in various ways, but people with nerve injuries frequently have a dysfunctional pain reduction system, making them particularly prone to distress. Now researchers have found that virtual reality (VR) can reduce types of pain typically found in patients with nerve injuries – which VR can raise the dysfunctional pain suppression

    Researcher find a gene mutation connected to schizophrenia

    Researchers at The Feinstein Institutes for Medical Research, in collaboration with Columbia University, have identified a gene mutation that could result in schizophrenia, a chronic brain disease that affects nearly 1 percent of the planet’s inhabitants. The findings, published in today in Neuron, could lead to novel treatment strategies. The research group, headed by Todd

    Imbalanced bacterial community in the gums connected to Alzheimer’s infection biomarker

    Older adults with more harmful than healthy bacteria in their gums are more likely to have evidence for amyloid beta–a key biomarker for Alzheimer’s disease–in their cerebrospinal fluid (CSF), according to new research from NYU College of Dentistry and Weill Cornell Medicine. However, this imbalance in oral bacteria was not associated with another Alzheimer’s biomarker

    FDA supports new medication for therapy of adults with chronic kidney infection

    Today, the U.S. Food and Drug Administration accepted Farxiga (dapagliflozin) oral tablets to decrease the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Chronic kidney disease occurs when the kidneys are damaged and can’t filter blood

    Unevenness in gut microbiota could assume a vital part in movement of inflammatory skin disorder

    Findings presented at the EADV 2021 Spring Symposium imply that an imbalance in gut microbiota (dysbiosis), could play a substantial role in the progression of inflammatory skin disease, Hidradenitis Suppurativa (HS). HS is a painful, long-term skin condition, with a chronic and relapsing nature that significantly impacts patients’ quality of life. Researchers at Hacettepe University

    UCL researchers distinguish new immunotherapy to battle hepatitis B infection

    Researchers at UCL have identified a new immunotherapy to fight the hepatitis B virus (HBV), the most frequent cause of liver cancer in the world. The pioneering study used immune cells isolated directly from patient liver and tumour tissue, to demonstrate that targeting acyl-CoA:cholesterol acyltransferase (ACAT), an enzyme which helps to manage cholesterol levels in